CFS Investment Advisory Services LLC trimmed its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 51.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 27,831 shares of the company's stock after selling 29,213 shares during the quarter. CFS Investment Advisory Services LLC's holdings in Procter & Gamble were worth $4,820,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. POM Investment Strategies LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $34,000. Quest Partners LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $44,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the stock. DA Davidson reiterated a "neutral" rating and issued a $160.00 price objective on shares of Procter & Gamble in a research note on Wednesday. JPMorgan Chase & Co. increased their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a research note on Thursday, September 19th. DZ Bank upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 price objective on the stock in a research note on Thursday, August 29th. Dbs Bank cut shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 1st. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $178.00.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Trading Up 2.0 %
NYSE PG traded up $3.53 on Friday, hitting $176.28. 9,654,531 shares of the stock were exchanged, compared to its average volume of 6,685,478. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a fifty day moving average price of $170.00 and a two-hundred day moving average price of $168.54. The firm has a market capitalization of $415.15 billion, a P/E ratio of 30.48, a P/E/G ratio of 3.69 and a beta of 0.42. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business's revenue was down .6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.83 earnings per share. Research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio is currently 69.48%.
Insider Activity
In related news, CEO Jon R. Moeller sold 87,979 shares of Procter & Gamble stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.40, for a total value of $14,991,621.60. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at $51,252,400.80. The trade was a 22.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares of the company's stock, valued at $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 160,693 shares of company stock valued at $27,311,345. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Company Profile
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.